Earnings reversal trade on $INCYStock gapped down on earnings and now the candle is showing demand. I would start a small position here and put stop around 8%. NASDAQ:INCY
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.210 EUR
31.51 M EUR
4.10 B EUR
194.18 M
About Incyte Corporation
Sector
Industry
CEO
William J. Meury
Website
Headquarters
Wilmington
Founded
1991
ISIN
US45337C1027
FIGI
BBG003899MC4
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Related stocks
INCY is about to Break OutIncyte is ready to Break Out in couple of days. its prior move and follow up in a range movement give indication it is ready to go.
Average Patent ValueGiven Incyte’s 350 active patents, each worth an average of $5 million by my calculations, the company could be valued at $17 billion. That’s right at the top of the fair value range! #Biotechnology #PatentValue
INCY looks good!INCY
Very tight at the bottom of the box, low risk entry in the demand area. High profit potential
Incyte Corp.Incyte Corp. witnessed a rebound after attempting to test the support level at 61.89, to close below the minor resistance 63.05, which is the level that needs to be violated to confirm the current positivity, which will trigger further rises near 62.65 - 65 - 65.61 - 66.43 - 67.40.
The stop-loss l
INCY setting up for a Base BreakoutINCY has been basing for a few months under this $66 level
Keep an eye out for the exit of the stage 1 base into a stage 2 breakout through $66 to the upside
INCY - Incyte Bullish BreakoutOn this 5 Month Daily Chart of Incyte you can clearly see the Bearish Trend that included the last 6 weeks of each daily candle trending below the 7 Day EMA until just the last 2 trading days where the bottom was made and INCY finally broke above the 7 day EMA on very good strenth with much higher v
INCY Buy Opportunity "Pause Rebounders "Pause Rebounder Stock
Market Watch:
Because until equity markets begin to notice. it’s unlikely politicians will feel compelled to act. Political brinkmanship will fuel market volatility — the VIX (VIX) trades to 40 in 2023; SPX retests the 3,800 floor. The similarities to 2011 (where arguably Dem
$INCY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $INCY after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 85.71%.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ICY is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange Incyte Corporation stocks are traded under the ticker ICY.
We've gathered analysts' opinions on Incyte Corporation future price: according to them, ICY price has a max estimate of 112.02 EUR and a min estimate of 60.79 EUR. Watch ICY chart and read a more detailed Incyte Corporation stock forecast: see what analysts think of Incyte Corporation and suggest that you do with its stocks.
Yes, you can track Incyte Corporation financials in yearly and quarterly reports right on TradingView.
Incyte Corporation is going to release the next earnings report on Feb 18, 2026. Keep track of upcoming events with our Earnings Calendar.
ICY earnings for the last quarter are 1.93 EUR per share, whereas the estimation was 1.37 EUR resulting in a 40.71% surprise. The estimated earnings for the next quarter are 1.68 EUR per share. See more details about Incyte Corporation earnings.
Incyte Corporation revenue for the last quarter amounts to 1.16 B EUR, despite the estimated figure of 1.07 B EUR. In the next quarter, revenue is expected to reach 1.16 B EUR.
ICY net income for the last quarter is 361.47 M EUR, while the quarter before that showed 343.81 M EUR of net income which accounts for 5.14% change. Track more Incyte Corporation financial stats to get the full picture.
No, ICY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 29, 2025, the company has 2.62 K employees. See our rating of the largest employees — is Incyte Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Incyte Corporation EBITDA is 1.15 B EUR, and current EBITDA margin is 3.99%. See more stats in Incyte Corporation financial statements.
Like other stocks, ICY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Incyte Corporation stock right from TradingView charts — choose your broker and connect to your account.